A Potential Covid Breakthrough; CNBC Disruptors: Stripe CEO

A Potential Covid Breakthrough; CNBC Disruptors: Stripe CEO

  • Af
  • Episode
      244
  • Published
      16. jun. 2020
  • Forlag
0 Anmeldelser
0
Episode
244 of 1789
Længde
31M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

An Oxford University trial revealed that Dexamethasone, a common and inexpensive steroid, has been shown to improve survival rates in some Covid-19 patients. CNBC’s Meg Tirrell and Former FDA Commissioner Dr. Scott Gottlieb discuss the significance of this finding and its impact on health workers, global hope, and U.S. markets. CNBC has unveiled its annual list of Disruptors, a group of 50 up-and-coming companies disrupting industries and legacy brands. Number one on the list: payment platform Stripe. CEO John Collison shares how his platform’s been helping businesses stay afloat throughout the pandemic, and how he plans to keep his own business growing.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
DK - Details page - Device banner - 894x1036
Cover for A Potential Covid Breakthrough; CNBC Disruptors: Stripe CEO

Other podcasts you might like ...